Manufacturing / Biological Products, Except Diagnostic Substances
Beam Therapeutics Inc.
BEAM
$31.15
+$2.86 (+10.09%)
Price as of Aug 25, 2026 17:45 UTC
2.9 B
Market Cap (Mid Cap)
46%
IV Rank
84.7%
Implied Volatility
Nov 02
Next Earnings
Price & Trend
Daily candles with EMA 20, SMA 50. Drag to zoom.
Options Activity & Greeks
Implied volatility, flow, and dealer positioning from the options market.
Put/Call Ratio
0.01
Bullish skew
Implied Volatility
84.7%
1% percentile
IV vs Realized
Options rich
30d HV 71.0%
Options Heat Map
Delta-risk grid for BEAM options across strikes and expirations. Hover any cell for full Greeks.
Loading option chain data...
Insider Trades
0 buys
34 sells
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| Jul 27, 2026 | Simon Amy | Sell | 16,667 | $429,037 | |
| Jun 30, 2026 | Simon Amy | Sell | 373 | $12,954 | |
| Jun 30, 2026 | Evans John M. | Exercise | 25,000 | $0 | |
| Jun 30, 2026 | Evans John M. | Sell | 1,900 | $66,203 | |
| Jun 30, 2026 | Evans John M. | Sell | 23,100 | $791,482 | |
| Jun 30, 2026 | Evans John M. | Exercise | 25,000 | $25,750 | |
| Jun 29, 2026 | Evans John M. | Exercise | 6,337 | $0 | |
| Jun 29, 2026 | Evans John M. | Exercise | 18,663 | $0 | |
| Jun 29, 2026 | Evans John M. | Sell | 11,579 | $415,824 | |
| Jun 29, 2026 | Evans John M. | Sell | 13,421 | $471,528 |
Earnings History
| Date | Quarter | EPS Est. | EPS Actual | Surprise | Result |
|---|---|---|---|---|---|
| Aug 11, 2026 | Q2 2026 | -$1.13 | |||
| Aug 03, 2026 | Q2 2026 | -$1.13 | |||
| Jun 30, 2026 | Q2 2026 | -$1.13 | -$1.18 | -4.6% | Miss |
| Mar 31, 2026 | Q1 2026 | -$1.12 | -$0.91 | +18.6% | Beat |
| Dec 31, 2025 | Q4 2025 | -$1.01 | -$0.10 | +89.8% | Beat |
| Sep 30, 2025 | Q3 2025 | -$1.06 | -$1.10 | -3.7% | Miss |
Track BEAM with ThetaPal
Get insider trade alerts, AI portfolio analysis, and options roll recommendations for BEAM and your entire portfolio.